Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CELC · against 301 other Healthcare companies of similar size
Ranked #252 of 302 · scores higher than 15% of peers
Bars: peers in each 10-point band of the profitability score29 peers with a profitability score of 20–29, including CELC · Click a bar to see the companies
Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | CELC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 293 reported | -29.5% | 7.5% | 14% | 33% | |
| Operating marginHigher is better · 278 reported | Not reported | 9.9% | — | — | 33% |
| Return on assetsHigher is better · 285 reported | -27.3% | 2.7% | 12% | 33% | |
| Return on equityHigher is better · 280 reported | -1433.7% | 6.9% | 0% | Context only | |
| Gross marginHigher is better · 309 reported | 0.0% | 47.6% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 245 | 2.0B USD | 22 | 29 | |
| 249 | 2.6B USD | 21 | 43 | |
| 249 | 2.8B USD | 21 | 22 | |
| 249 | 2.2B USD | 21 | 23 | |
| 252 | 3.4B USD | 20 | 17 | |
| 252 | 4.7B USD | 20 | 46 | |
| 252 | 3.0B USD | 20 | 54 | |
| 252 | 6.7B USD | 20 | 19 | |
| 252 | 1.8B USD | 20 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score